Stocks
BioMarin Pharmaceutical (BMRN) EV/EBITDA US GAAP (year values) |
||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| EV/EBITDA | ? | 114.5 | 71.5 | 59.1 | 18.4 | 18.3 | 20.7 | |
| Changes by years, y/y, % | -38% | -17% | -69% | -1% | ||||
BioMarin Pharmaceutical. EV/EBITDA
BioMarin Pharmaceutical. EV/EBITDA, changes, %
BioMarin Pharmaceutical (BMRN) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EV/EBITDA | ? | 16.5 | 10.4 | 12.3 | 18.3 | 21.7 | 20.7 | |
| Changes by years, y/y, % | -64% | -72% | -52% | -1% | +32% | |||
| Changes by quarters, q/q, % | -10% | -37% | +19% | +48% | +19% | |||
